Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/1996
12/19/1996CA2220958A1 Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands
12/19/1996CA2220076A1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
12/19/1996CA2219981A1 Method for regulating metabolism with dopamine beta hydroxylase inhibitors
12/19/1996CA2219977A1 Method for regulating glucose metabolism
12/19/1996CA2219755A1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
12/19/1996CA2219417A1 Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists
12/18/1996EP0748795A2 Substituted benzyloxycarbonyl guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agents as well as medicament containing them
12/18/1996EP0748793A1 Ketopanthenol with acetylating properties
12/18/1996EP0748792A1 Calcium ketopantothenate with acetylating properties
12/18/1996EP0748320A1 Prodrugs of morpholine tachykinin receptor antagonists
12/18/1996EP0748315A1 Use of imidazole derivatives for treating disorders involving angiotensin receptors at 1? and at 2?, certain such products, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing same
12/18/1996EP0748314A1 Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same
12/18/1996EP0748219A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
12/18/1996EP0748213A1 Methods and compositions for pulmonary delivery of insulin
12/18/1996EP0635011B1 Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans
12/18/1996EP0526598B1 New pharmacologically active catechol derivatives
12/18/1996CN1138350A CNTF Family antagonists
12/18/1996CN1138335A Compounds with growth hormone releasing properties
12/18/1996CN1138334A Compounds with growth hormone releasing properties
12/18/1996CN1138332A Pyridazino quinoline compounds
12/18/1996CN1138040A New cyclohexane compounds, process for their preparation and pharmaceutical compositions containing them
12/18/1996CN1138037A Adhesion receptor antagonists
12/18/1996CN1138029A Fluorophenyl sbstd. alkenylc arboxylic acid-guanidine its preparation method, applied as medicine and diagnosis agent and medicine containing the compound
12/17/1996US5585462 Cloning of perilipin proteins
12/17/1996US5585390 Alpha-amino acid compounds
12/17/1996US5585376 1,5-benzodiazepine derivatives having CCK and/or gastrin antagonistic activity
12/17/1996US5585374 Anxiolytic agents, antidepressants, cognition activators
12/17/1996US5585368 Skin disorders
12/17/1996US5585366 Lowering blood cholesterol levels using water soluble cellulose ethers
12/17/1996US5585089 Humanized immunoglobulins
12/12/1996WO1996039515A1 Human vascular endothelial growth factor 2
12/12/1996WO1996039510A1 Chimeric proteins for use in transport of a selected substance into cells
12/12/1996WO1996039449A1 Hydrophobic heteroatom-containing sequestrant for cholesterol depletion
12/12/1996WO1996039439A1 Human g-protein receptor hcegh45
12/12/1996WO1996039400A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
12/12/1996WO1996039385A1 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
12/12/1996WO1996039168A1 Method for increasing hdl cholesterol level
12/12/1996WO1996039164A1 Use of angiotensin ii type 2 receptor agonists in tissue repair
12/12/1996WO1996039162A1 Regulation of eating behavior
12/12/1996WO1996039156A2 Phosphate-binding polymers for oral administration
12/12/1996WO1996039138A1 Methods for minimizing bone loss
12/12/1996WO1996011949A3 Analogs of keratinocyte growth factor
12/12/1996CA2223307A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
12/12/1996CA2223177A1 Method for increasing hdl cholesterol level
12/12/1996CA2223153A1 Regulation of eating behavior
12/12/1996CA2223055A1 Methods for minimizing bone loss
12/12/1996CA2221711A1 Chimeric proteins for use in transport of a selected substance into cells
12/12/1996CA2221637A1 Human g-protein receptor hcegh45
12/12/1996CA2218531A1 Hydrophobic heteroatom-containing sequestrant for cholesterol depletion
12/11/1996EP0747395A1 Composition for treating renal failure
12/11/1996EP0747380A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/11/1996EP0747378A1 Dihydropyridine NPY antagonists
12/11/1996EP0747377A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/11/1996EP0747376A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/11/1996EP0747357A2 Dihydropyridine NPY antagonists: piperidine derivatives
12/11/1996EP0747356A1 Dihydropyridine NPY antagonists: piperazine derivatives
12/11/1996EP0747353A2 Indole derivatives
12/11/1996EP0747347A1 RARy-specific retinobenzoic acid derivatives
12/11/1996EP0747054A2 Methods for minimizing bone loss
12/11/1996EP0747033A1 Transfusion liquid-containing holder and prepared transfusion liquid
12/11/1996EP0746335A1 Medical application of bromelain
12/11/1996EP0746332A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof
12/11/1996EP0746321A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
12/11/1996EP0746312A1 Guanylhydrazones for treating inflammatory conditions
12/11/1996EP0746202A1 Pharmaceutically active antioxydant containing composition and the method of its use to prevent and treat restenosis following angioplasty
12/11/1996CN1137753A Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
12/11/1996CN1137411A "Kangfuyidao Jiangtangdan" Chinese medicine for reducing blood sugar and recovering islets of pancreas and its preparation method
12/10/1996US5583221 Antiinflammatory agents, cardiovascular disorders, viricides, fungicides
12/10/1996US5583130 Benzo-fused lactams promote release of growth hormone
12/10/1996US5583125 25-Carboxylic acid derivatives in the vitamin D series, process for their production, intermediate products for these processes, pharmaceutical preparations containing these derivatives as well as their use for the production of pharmaceutical agents
12/10/1996US5583117 Acylated uridine and cytidine for elevating tissue uridine and cytidine
12/10/1996US5583019 Culturing microorganisms of the genus mortierella sect. schmuckeri; recovering microorganisms
12/10/1996US5582995 Methods of screening for compounds which inhibit the direct binding of Ras to Raf
12/10/1996US5582591 Delivery of solid drug compositions
12/10/1996CA2017285C Stabilized calcitonin pharmaceutical composition
12/10/1996CA2007983C Coenzyme q10 with hmg-coa reductase inhibitors
12/08/1996CA2178414A1 Dihydropyridine npy antagonists: nitrogen heterocyclic derivatives
12/08/1996CA2178413A1 Dihydropyridine npy antagonists: piperazine derivatives
12/08/1996CA2178184A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/08/1996CA2178183A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/08/1996CA2178182A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/08/1996CA2177110A1 Dihydropyridine npy antagonists: piperidine derivatives
12/07/1996CA2175854A1 Rar(gamma)-specific retinobenzoic acid derivatives
12/05/1996WO1996038471A1 Dipeptides which promote release of growth hormone
12/05/1996WO1996038457A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996WO1996038437A1 Process for the production of lipoic acid
12/05/1996WO1996038428A1 N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same
12/05/1996WO1996038426A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996WO1996038415A1 Novel 2-amino-3-phenylpropionic acid derivatives
12/05/1996WO1996038412A1 Novel compounds and anti-dermatitis drug
12/05/1996WO1996038167A1 Use of fibroblast growth factors to stimulate bone growth
12/05/1996WO1996038157A1 Inhibitor for lipid peroxide increase
12/05/1996WO1996038156A1 Use of alendronate for the prevention of osteoporosis
12/05/1996WO1996038134A1 Use of aryl substituted cyclobutyl alkyl amines for the treatment of obesity
12/05/1996WO1996038047A1 Fat based food products
12/05/1996DE19518988A1 Verwendung arylsubstituierter Cyclobutylalkylamine zur Behandlung der Fettleibigkeit Use of aryl-substituted Cyclobutylalkylamine for the treatment of obesity
12/05/1996CA2223276A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996CA2222318A1 Use of alendronate for the prevention of osteoporosis
12/05/1996CA2222147A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996CA2218918A1 The use of aryl-substituted cyclobutylalkylamines for treating obesity
1 ... 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 ... 1298